Showing results (61-70 of 314) with videos related to
Sort By:
Pageof 32
Therapeutic Advances in Musculoskeletal Disease|July 7, 2022
Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)Diederik De Cock, Elena Myasoedova, Daniel Aletaha, et al.Annals of the Rheumatic Diseases|October 23, 2012
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritisChristoph Böhler, Helga Radner, Josef S Smolen, et al.Arthritis and Rheumatism|July 20, 2012
Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activityPaul Studenic, Helga Radner, Josef S Smolen, et al.Annals of the Rheumatic Diseases|September 27, 2023
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritisVictoria Konzett, Andreas Kerschbaumer, Josef S Smolen, et al.Annals of the Rheumatic Diseases|March 8, 2011
Reporting of long-term extension studies: lack of consistency calls for consensusMaya H Buch, Daniel Aletaha, Paul Emery, et al.Annals of the Rheumatic Diseases|June 20, 2022
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritisAndreas Kerschbaumer, Zaïda Iasha Rivai, Josef S Smolen, et al.Journal of Clinical Medicine|December 15, 2019
Pseudoerosions of Hands and Feet in Rheumatoid Arthritis: Anatomic Concepts and RedefinitionLena Hirtler, Claus Rath, Hannes Platzgummer, et al.Annals of the Rheumatic Diseases|May 7, 2020
Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumabInbal Haya Shafran, Farideh Alasti, Josef S Smolen, et al.Joint Bone Spine|June 30, 2009
Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitisSteven R Ytterberg, Kenneth J Warrington, Daniel Aletaha, et al.Arthritis and Rheumatism|October 2, 2007
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patientsDaniel Aletaha, Julia Funovits, Edward C Keystone, et al.Pageof 32